Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Payer Perspective and Value of Treatment of SMA
August 12, 2019 – 
Surya Singh, MD, provides a payer perspective on the value of treatment for patients with SMA.
Challenges of Payer Criteria and Cost of Therapy for SMA
August 12, 2019 – 
The panel shares challenges providers have based on payer criteria and the impact of cost of therapy.
Knowledge Among Payers and Payer Requirements for Rare Disease
August 05, 2019 – 
Surya Singh, MD, shares his thoughts on the knowledge payers have regarding rare diseases and the requirements for approval.
ENDEAR Study, Patient Factors, and Drug Approval Criteria
August 05, 2019 – 
Panelists share data from the ENDEAR study, including patient factors for its use, and also provide insights on the drug approval criteria.
How Real-World Data Can Address Problems in MM
August 02, 2019 – 
Experts examine how real-world data can help address some of the practical, personal, and economic issues that arise during treatment for multiple myeloma.
Dosing Strategies in Relapsed-Refractory MM
August 02, 2019 – 
A review of the dosing strategies based on data from the ARROW study, for relapsed or refractory multiple myeloma.
Osteoporosis: Using Novel Therapies in Practice
August 01, 2019 – 
Perspective regarding the future utilization of novel therapies for the management of patients with osteoporosis.
Approval of Nusinersen for SMA
July 29, 2019 – 
John Brandsema, MD, introduces us to nusinersen, an FDA-approved treatment option for spinal muscular atrophy.
Treatment Goals and Multidisciplinary Management of SMA
July 29, 2019 – 
Experts review the goals of treatment for patients with spinal muscular atrophy and the multidisciplinary management of symptoms.
Daratumumab in the Treatment Landscape for MM
July 26, 2019 – 
Examining how daratumumab and other monoclonal antibodies will enhance results in the frontline treatment of multiple myeloma.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.